FDA requires warning on GLP-1 drugs over rare eye condition @WISHNews8
FDA requires warning on GLP-1 drugs over rare eye condition  @WISHNews8
Uploaded November 2026 | Updated November 2026, 1 day ago
The Food and Drug Administration is requiring GLP-1 agonist medications to carry a warning about a potential increased risk of a rare, serious eye condition.

FULL STORY: wishtv.com/news/health-spotlight/fda-requires-warning-on-glp-1-drugs-over-rare-eye-condition

——————————————————————————————
WISH-TV website | wishtv.com
Follow us!
facebook.com/WISHNews8
instagram.com/WISH8News
tiktok.com/@WISHNews8
twitter.com/WISHNews8
threads.net/@wish8news
https://bsky.app/wishtv.com

Download the WISH-TV App | bit.ly/3vMkd5q
Subscribe to the WISH-TV Newsletter | wishtv.com/email-alerts
Have a news tip? Email us at news@wishtv.com
FDA requires warning on GLP-1 drugs over rare eye conditionBands of America Grand Nationals brings nearly 100 marching bands to IndianapolisVision Zero sees progress in traffic safety planTesting kids vitamins and supplements‘Great Day TV’: American Village hosts 12th annual pet photo fundraiser for Alzheimer’s researchBen Davis vs Brownsburg in Sectional Championship Showdown2 people found dead inside Greenwood, Indiana, home; from News 8 at 10 p.m. Aug. 4, 2025Local Fiber Arts company offers classes on wool creationsCounties report record midterm early votingMozel Sanders Foundation continues Thanksgiving tradition of feeding thousands in IndianapolisHamilton County Democrats look ahead after flipping 22 of 41 seats on election nightMan arrested for July hit-and-run crash
WISH-TV |

FDA requires warning on GLP-1 drugs over rare eye condition

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER